| References |
| 1 |
O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes. J Pharmacol Exp Ther. 2002 Jan;300(1):105-11.
|
| 2 |
Simultaneous identification and quantitation of fluoxetine and its metabolite, norfluoxetine, in biological samples by GC-MS
|
| 3 |
DrugBank(Pharmacology-Metabolism):Fluoxetine hydrochloride
|
| 4 |
DrugBank(Pharmacology-Metabolism):Isocarboxazid
|
| 5 |
Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates
|
| 6 |
Midostaurin, a novel protein kinase inhibitor for the treatment of acute myelogenous leukemia: insights from human absorption, metabolism, and excretion studies of a BDDCS II drug. Drug Metab Dispos. 2017 May;45(5):540-555.
|
| 7 |
DrugBank(Pharmacology-Metabolism)Amphetamine
|
| 8 |
Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and Lactobacillus rhamnosus. Eur J Nutr. 2018 Feb;57(1):231-242.
|
| 9 |
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
|
| 10 |
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. Neuropharmacology. 2014 Dec;87:41-50.
|
| 11 |
Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose
|
| 12 |
In vitro catabolism of 3',4'-dihydroxycinnamic acid by human colonic microbiota
|
| 13 |
Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate
|
